The future of healthcare

A new vaccine trial is just one of many exciting developments in the field of biotechnology.

By Johan Fourie

in early February 2021, the findings of a new vaccine trial were announced. While the news was only picked up by a few South African news outlets, the implications could be more profound for SA’s future than any Covid-19-related news. This is because the trial 1 results of the vaccine candidate showed a breakthrough in producing rare immune cells necessary to prevent the deadliest of pandemics in southern Africa, one that has ravaged the subcontinent for almost three decades: HIV/Aids. Statistics SA estimates that about a quarter of all annual deaths in SA – around 125 000 people – is attributed to Aids. Those numbers suggest that an HIV vaccine would improve the lives of millions of South Africans, raising life expectancy, reducing morbidity and the consequent (private and public) expenditure…

You're reading a preview of

Finweek - English (Digital) - 1 Issue, 3/4/2021

DiscountMags is a licensed distributor (not a publisher) of the above content and Publication through Zinio LLC. Accordingly, we have no editorial control over the Publications. Any opinions, advice, statements, services, offers or other information or content expressed or made available by third parties, including those made in Publications offered on our website, are those of the respective author(s) or publisher(s) and not of DiscountMags. DiscountMags does not guarantee the accuracy, completeness, truthfulness, or usefulness of all or any portion of any publication or any services or offers made by third parties, nor will we be liable for any loss or damage caused by your reliance on information contained in any Publication, or your use of services offered, or your acceptance of any offers made through the Service or the Publications. For content removal requests, please contact Zinio.